Social stigma still exists for some medical disorders and compounds the challenges health problems create.  For migraineurs, the stigma is high. In fact, researchers say, individuals who experience chronic migraine report lower quality of life and more social stigma—stereotyping, discrimination and loss of status—than those with episodic migraine or epilepsy, a disease that, unfortunately, has traditionally carried considerable stigma.

Migraine and epilepsy, which often occur together, may share a genetic link, according to research reported online this month in the journal Epilepsia.
Individuals with epilepsy are far more likely than those in the general population to experience migraine. The new findings, however, provide researchers considerably more insight into the link between the two disorders, specifically epilepsy and migraine with aura.

Topiramate (Topamax®) is the most important advance in migraine prevention, according to two Norwegian headache specialists writing in The Lancet. The antiseizure drug has long been used to treat epilepsy, but received FDA approval for migraine prevention in 2004.

The invisibility of headaches increases the stigma surrounding them, especially for people with chronic migraines, according to a team of researchers from the Jefferson Headache Clinic at Thomas Jefferson University Hospital in Philadelphia. In fact, chronic migraine sufferers experience more stigma than people with stroke, epilepsy or multiple sclerosis.

Epilepsy has been linked to migraine headaches. They are comorbid conditions, which means if you have one of them, there is a greater likelihood of having the other. In most cases, however, it is a matter of a patient with two different neurologic conditions with occasional overlapping of symptoms. Patients with epilepsy may at times have a "postictal" or "post-seizure" headache. This headache is diffuse, throbbing, and moderate and subsides over a number of hours.